227 related articles for article (PubMed ID: 33316582)
1. Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysis.
Kim DY; Park E; Heo CY; Jin US; Kim EK; Han W; Shin KH; Kim IA
Breast; 2021 Feb; 55():37-44. PubMed ID: 33316582
[TBL] [Abstract][Full Text] [Related]
2. Influence of Hypofractionated Versus Conventional Fractionated Postmastectomy Radiation Therapy in Breast Cancer Patients With Reconstruction.
Kim DY; Park E; Heo CY; Jin US; Kim EK; Han W; Shin KH; Kim IA
Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):445-456. PubMed ID: 34610389
[TBL] [Abstract][Full Text] [Related]
3. Survival Outcomes of Post-mastectomy Breast Cancer Patients Treated with Hypofractionated Radiation Treatment Compared to Conventional Fractionation -a Retrospective Cohort Study.
Raveendran C; Meloot SS; Yadev I
Gulf J Oncolog; 2023 May; 1(42):26-34. PubMed ID: 37283257
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis.
Dong J; Yang Y; Han D; Zhao Q; Liu C; Sun H; Wang Z; Lin H; Huang W
Technol Cancer Res Treat; 2021; 20():15330338211064719. PubMed ID: 34898315
[No Abstract] [Full Text] [Related]
5. A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose.
Hong Z; Yang Z; Mei X; Li P; Bao C; Wang Z; Cai X; Ming X; Wang W; Guo X; Yu X; Zhang Q
Radiat Oncol; 2023 Mar; 18(1):56. PubMed ID: 36959653
[TBL] [Abstract][Full Text] [Related]
6. Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review.
Liu L; Yang Y; Guo Q; Ren B; Peng Q; Zou L; Zhu Y; Tian Y
Radiat Oncol; 2020 Jan; 15(1):17. PubMed ID: 31952507
[TBL] [Abstract][Full Text] [Related]
7. Update on Accelerated Whole Breast Irradiation.
Shah C; Fleming-Hall E; Asha W
Clin Breast Cancer; 2023 Apr; 23(3):237-240. PubMed ID: 36792457
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.
Wang SL; Fang H; Song YW; Wang WH; Hu C; Liu YP; Jin J; Liu XF; Yu ZH; Ren H; Li N; Lu NN; Tang Y; Tang Y; Qi SN; Sun GY; Peng R; Li S; Chen B; Yang Y; Li YX
Lancet Oncol; 2019 Mar; 20(3):352-360. PubMed ID: 30711522
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity.
Deantonio L; Gambaro G; Beldì D; Masini L; Tunesi S; Magnani C; Krengli M
Radiat Oncol; 2010 Nov; 5():112. PubMed ID: 21092288
[TBL] [Abstract][Full Text] [Related]
10. Impact of radiation dose on complications among women with breast cancer who underwent breast reconstruction and post-mastectomy radiotherapy: A multi-institutional validation study.
Chung SY; Chang JS; Shin KH; Kim JH; Park W; Kim H; Kim K; Lee IJ; Yoon WS; Cha J; Lee KC; Kim JH; Choi JH; Ahn SJ; Ha B; Lee SY; Lee DS; Lee J; Shin SO; Lee SW; Choi J; Kim MY; Kim YJ; Im JH; Suh CO; Kim YB
Breast; 2021 Apr; 56():7-13. PubMed ID: 33517043
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated radiotherapy for breast cancers--preliminary results from a tertiary care center in eastern India.
Nandi M; Mahata A; Mallick I; Achari R; Chatterjee S
Asian Pac J Cancer Prev; 2014; 15(6):2505-10. PubMed ID: 24761855
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients.
Koukourakis MI; Giatromanolaki A; Kouroussis C; Kakolyris S; Sivridis E; Frangiadaki C; Retalis G; Georgoulias V;
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):144-55. PubMed ID: 11777632
[TBL] [Abstract][Full Text] [Related]
13. Significance of Hypofractionated Radiotherapy in Postoperative Irradiation for Breast Cancer: An Asian Multi-institutional Prospective Study.
Okonogi N; Kono S; Karasawa K; Banu PA; Xu X; Erawati D; Adylkhanov T; Jang WI; E Y; Calaguas MJ; Thephamongkhol K; Dung TA; Ng WNP; Kato S;
Clin Oncol (R Coll Radiol); 2023 Jul; 35(7):463-471. PubMed ID: 37179216
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 cases.
Doré M; Cutuli B; Cellier P; Campion L; Le Blanc M
Radiat Oncol; 2015 Aug; 10():161. PubMed ID: 26238442
[TBL] [Abstract][Full Text] [Related]
15. Acute radiation-induced skin toxicity in hypofractionated vs. conventional whole-breast irradiation: An objective, randomized multicenter assessment using spectrophotometry.
Schmeel LC; Koch D; Schmeel FC; Röhner F; Schoroth F; Bücheler BM; Mahlmann B; Leitzen C; Schüller H; Tschirner S; Fuhrmann A; Heimann M; Brüser D; Abramian AV; Müdder T; Garbe S; Vornholt S; Schild HH; Baumert BG; Wilhelm-Buchstab TM
Radiother Oncol; 2020 May; 146():172-179. PubMed ID: 32171945
[TBL] [Abstract][Full Text] [Related]
16. Conventional Versus Different Hypofractionated Radiotherapy Dosage Schedules in Postmastectomy Advanced Breast Cancer.
Jain N; Sharma R; Sachdeva K; Kaur A; Sudan M
J Med Phys; 2022; 47(2):141-144. PubMed ID: 36212213
[TBL] [Abstract][Full Text] [Related]
17. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
Widmark A; Gunnlaugsson A; Beckman L; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Fransson P; Tavelin B; Norman D; Zackrisson B; Anderson H; Kjellén E; Franzén L; Nilsson P
Lancet; 2019 Aug; 394(10196):385-395. PubMed ID: 31227373
[TBL] [Abstract][Full Text] [Related]
18. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
[TBL] [Abstract][Full Text] [Related]
19. Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial.
Mutter RW; Giri S; Fruth BF; Remmes NB; Boughey JC; Harless CA; Ruddy KJ; McGee LA; Afzal A; Gao RW; Shumway DA; Vern-Gross TZ; Villarraga HR; Kenison SL; Kang Y; Wong WW; Stish BJ; Merrell KW; Yan ES; Park SS; Corbin KS; Vargas CE
Lancet Oncol; 2023 Oct; 24(10):1083-1093. PubMed ID: 37696281
[TBL] [Abstract][Full Text] [Related]
20. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
